BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1569606)

  • 1. Dose-ranging trial of zacopride: the emetic antiemetic?
    Pisters KM; Kris MG; Tyson LB; Clark RA; Gralla RJ
    J Natl Cancer Inst; 1992 May; 84(9):717-8. PubMed ID: 1569606
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the emetic and antiemetic properties of zacopride and its enantiomers.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1991 Jan; 192(3):365-9. PubMed ID: 2055236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emetic activity of zacopride in ferrets and its antagonism by pharmacological agents.
    Sancilio LF; Pinkus LM; Jackson CB; Munson HR
    Eur J Pharmacol; 1990 Jun; 181(3):303-6. PubMed ID: 2384137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.
    Smith WL; Callaham EM; Alphin RS
    J Pharm Pharmacol; 1988 Feb; 40(2):142-3. PubMed ID: 2897451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
    King GL
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1034-41. PubMed ID: 2162943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
    King GL; Landauer MR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1026-33. PubMed ID: 2359014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiemetic profile of zacopride.
    Smith WL; Alphin RS; Jackson CB; Sancilio LF
    J Pharm Pharmacol; 1989 Feb; 41(2):101-5. PubMed ID: 2568416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
    Young R; Johnson DN
    Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single dose pharmacokinetics and tolerance of pancopride in healthy volunteers.
    Dewland P; Pérez Campos A; Martinez-Tobed A
    Arzneimittelforschung; 1995 Feb; 45(2):177-83. PubMed ID: 7710444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical development of an antiemetic in oncology. A meta-analysis].
    Pérez Campos A
    Med Clin (Barc); 1994 Sep; 103(8):281-6. PubMed ID: 7967877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.
    Young R; Johnson DN
    Pharmacol Biochem Behav; 1991 Dec; 40(4):733-7. PubMed ID: 1687761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the risk concerns of zacopride, a moderate IK1 channel agonist with cardiac protective action.
    Wu BW; Cao JM
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):357-9. PubMed ID: 25072868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trial.
    Newcomer JW; Faustman WO; Zipursky RB; Csernansky JG
    Arch Gen Psychiatry; 1992 Sep; 49(9):751-2. PubMed ID: 1514881
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of the gastric symptoms of radiation sickness.
    Dubois A; Fiala N; Boward CA; Bogo V
    Radiat Res; 1988 Sep; 115(3):595-604. PubMed ID: 3174940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of DABIS maleate given once every 3 weeks.
    van der Burg ME; Planting AS; Stoter G; McDaniel C; Vecht CJ; Verweij J
    Eur J Cancer; 1991; 27(12):1635-7. PubMed ID: 1782074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors].
    Koscielniak T; Ponchant M; Laporte AM; Guminski Y; Verge D; Hamon M; Gozlan H
    C R Acad Sci III; 1990; 311(6):231-7. PubMed ID: 2121314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies.
    Lefebvre H; Contesse V; Delarue C; Soubrane C; Legrand A; Kuhn JM; Wolf LM; Vaudry H
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1662-6. PubMed ID: 8263156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact allergy to the cutting oil preservatives Bioban CS-1246 and P-1487.
    Dahlquist I
    Contact Dermatitis; 1984 Jan; 10(1):46. PubMed ID: 6231161
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.